Log in to save to my catalogue

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in...

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4da7287141b0461680db684780590f04

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease

About this item

Full title

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2021-12, Vol.18 (1), p.295-295, Article 295

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Parkinson's disease (PD) is characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc), accompanied by accumulation of α-synuclein, chronic neuroinflammation and autophagy dysfunction. Previous studies suggested that misfolded α-synuclein induces the inflammatory response and autophagy dysfunction in microgli...

Alternative Titles

Full title

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4da7287141b0461680db684780590f04

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4da7287141b0461680db684780590f04

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-021-02349-y

How to access this item